Alexandra Kropotova - 21 Nov 2024 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Director
Signature
/s/ Marc Banjak, Attorney-in-fact
Issuer symbol
IBIO
Transactions as of
21 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 16:32:50 UTC
Previous filing
23 Feb 2024
Next filing
31 Dec 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +18,900 $0.000000 18,900 21 Nov 2024 Common Stock 18,900 $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.